ArticleCentral European journal of urology2026
Enfortumab vedotin demonstrates consistent efficacy in platinum- and ICI-refractory metastatic urothelial carcinoma patients irrespective of prior response: a multicenter real-world study.
Shunsuke Watanabe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.